Cerevel Therapeutics

1D
1W
1M
3M
YTD
1Y
5Y
ALL

Why Robinhood?

Robinhood gives you the tools you need to put your money in motion. You can buy or sell CERE and other ETFs, options, and stocks.

About CERE

Cerevel Therapeutics Holdings, Inc. engages in the discovery and development of new therapies for neuroscience diseases. The firm's portfolio focuses on diseases such as schizophrenia, epilepsy, and Parkinson's disease. 

CEO
Ronald C. Renaud
CEORonald C. Renaud
Employees
334
Employees334
Headquarters
Cambridge, Massachusetts
HeadquartersCambridge, Massachusetts
Founded
2018
Founded2018
Employees
334
Employees334

CERE Key Statistics

Market cap
7.71B
Market cap7.71B
Price-Earnings ratio
-15.75
Price-Earnings ratio-15.75
Dividend yield
—
Dividend yield—
Average volume
1.14M
Average volume1.14M
High today
$42.49
High today$42.49
Low today
$41.94
Low today$41.94
Open price
$41.95
Open price$41.95
Volume
397.42K
Volume397.42K
52 Week high
$43.59
52 Week high$43.59
52 Week low
$19.59
52 Week low$19.59

Analyst ratings

83%

of 6 ratings
Buy
16.7%
Hold
83.3%
Sell
0%
All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, Member SIPC and a registered broker-dealer.